PER 2.50% 8.2¢ percheron therapeutics limited

Anyone surprised ?, page-91

  1. 3,237 Posts.
    lightbulb Created with Sketch. 275
    Here you are BG this is from financial report. I am sure you are wise enough to realise that
    transparency is not management's best quality:

    1 - administrative expenses. $ 555,102.00
    Corporate employee expense
    Office expense (printing, phone etc.)
    Compliance expense (ASX & related)
    Occupancy costs including rent and power



    2- Business development expense. $ 432,074.00
    Legal fees
    Travel and accommodation
    Consultancies
    Insurance
    Shareholder & investor relations
    Business development salaries and related oncost

    This is about developing revenue opportunities, not science ( developing revenue opportunities????????)


    3- Research and development expenses$ 446,483.00
    Patent fees
    Drug / compound development and maintenance
    Bio-analytics
    Cool storage
    Clinical trial activities
    Insurances
    Stability works
    Toxicology activities
    Couriers
    Travel
    Testing
    Licencing fees
    R&D salaries

    This is about developing science, not revenue.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 8.0¢ $216.5K 2.688M

Buyers (Bids)

No. Vol. Price($)
5 317461 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 285087 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.